Management of the diabetic Charcot foot
β Scribed by Robert G. Frykberg; Ewald Mendeszoon
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 120 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1520-7552
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of this longitudinal study was to report on the clinical characteristics and treatment course of acute Charcot's arthropathy at a tertiary care diabetic foot clinic. Fifty-five diabetic subjects, with a mean age of 58.6 +/- 8.5 years, were studied. All patients were treated with serial total
diabetes plus one or more additional cardiovascular risk factor. ACE inhibitors should now be considered alongside aspirin and statins for the prevention of cardiovascular disease in this high risk population. ## Key points $ Patients with diabetes are at very high cardiovascular risk $ In the HO
Increased Frequency of Diabetic Foot experiments they clearly support the latest lower extremity. In the 5 years 1992 Publications recommendations concerning the to 1996, a total of 1090 papers were published of which 3.8 % 42 related nutritional management of patients with Diabetic foot disease is